Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Shanghai Henlius Biotech (2696 HK)
Watchlist
109
Analysis
Health Care
•
China
Shanghai Henlius Biotech, Inc develops and produces drugs. The Company develops and produces monoclonal antibody biosimilar drugs, bio betters, novel monoclonal antibodys, and other drugs. Shanghai Henlius Biotech throughout China.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Cross Asset Strategy
•
29 Jun 2024 08:10
The Heat Is On: News Flow and Sentiment in HONG KONG
China had positive flows into equity ETF's for June and mainland investors continued to direct money to Hong Kong stocks through the Stock Connect...
David Mudd
Follow
447 Views
Share
bearish
•
Cross Asset Strategy
•
27 Jun 2024 12:52
•
Syndicated
CX Daily: Consumers, Entrepreneurs Give Banks’ Retail Lending a Much-Needed Boost
Retail lending / In Depth: Consumers, entrepreneurs give banks’ retail lending a much-needed boost Despite market saturation stunting the credit...
Caixin Global
Follow
141 Views
Share
bullish
•
Akeso Biopharma Inc
•
26 Jun 2024 08:41
What's Behind Akeso's Cadonilimab Price Cut and What's Next?
Akeso's proposition is to develop BsAb as a universal anti-cancer drug. Its revenue from Cadonilimab in the out-of-hospital market for Cervical...
Blue Lotus Research Institute
Follow
222 Views
Share
bearish
•
Shanghai Fosun Pharmaceutical (Group)
•
03 Jun 2024 08:55
Fosun Pharma (2196 HK/600196.CH) To Privatize Henlius (2696.HK) - Things Are Not as Good as Expected
Fosun Pharma's plan to privatize Henlius faces uncertainty due to cash-flow pressure.Shareholders' interests may suffer since Offer Price may not...
Xinyao (Criss) Wang
Follow
407 Views
Share
bullish
•
Sciclone Pharmaceuticals
•
29 May 2024 21:57
SciClone Pharma (6600 HK): Scheme Vote on 19 June
SciClone has received a letter of support from Pentwater Capital Management to vote YES. Pentwater represents 4.64% of out. shares and 8.51% of...
Arun George
Follow
746 Views
Share
First
Previous
4
5
6
7
8
9
10
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.34.2
x